The Videos

Features

Lobe Sciences Announces Update on Corporate Slide Deck Highlighting its Psilocin Compounds and Development Plans

Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors

PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease

Universal Ibogaine Provides Update on Kelburn Recovery Center